ACRIVON THERAPEUTICS, INC. Share Price Today: Live Updates & Key Insights
ACRIVON THERAPEUTICS, INC. share price today is $1.74, up 2.37%. The stock opened at $1.74 against the previous close of $1.69, with an intraday high of $1.755 and low of $1.715.
ACRIVON THERAPEUTICS, INC. Share Price Chart
ACRIVON THERAPEUTICS, INC.
ACRIVON THERAPEUTICS, INC. Share Price Performance
ACRIVON THERAPEUTICS, INC. Institutional Holdings
ACRIVON THERAPEUTICS, INC. Market Status
ACRIVON THERAPEUTICS, INC. Fundamentals
Market Cap 72.33 M
PB Ratio 0.6789
PE Ratio 0.0
Enterprise Value -30.48 M
Total Assets 129.72 M
Volume 302253
ACRIVON THERAPEUTICS, INC. Company Financials
About ACRIVON THERAPEUTICS, INC. & investment objective
Company Information Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 for the treatment of patients with endometrial and platinum-resistant ovarian cancer, and SCCs, such as SCCHN and anal cancer. The company is also developing ACR-2316, a dual WEE1 and PKMYT1 inhibitor small molecule candidate; and a preclinical stage AP3-and co-crystallography-based preclinical cell cycle program. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
Organisation Biotechnology
Employees 74
Industry Biotechnology
CEO Dr. Peter Blume-Jensen M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ACRIVON THERAPEUTICS, INC. FAQs
What is the share price of ACRIVON THERAPEUTICS, INC. today?
The current share price of ACRIVON THERAPEUTICS, INC. is $1.74.
Can I buy ACRIVON THERAPEUTICS, INC. shares in India?
Yes, Indian investors can buy ACRIVON THERAPEUTICS, INC. shares by opening an international trading and demat account with Motilal Oswal.
How to buy ACRIVON THERAPEUTICS, INC. shares in India?
You can easily invest in ACRIVON THERAPEUTICS, INC. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ACRIVON THERAPEUTICS, INC. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ACRIVON THERAPEUTICS, INC..
Can I buy fractional shares of ACRIVON THERAPEUTICS, INC.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ACRIVON THERAPEUTICS, INC.?
ACRIVON THERAPEUTICS, INC. has a market cap of $72.33 M.
In which sector does ACRIVON THERAPEUTICS, INC. belong?
ACRIVON THERAPEUTICS, INC. operates in the Biotechnology sector.
What documents are required to invest in ACRIVON THERAPEUTICS, INC. stocks?
To invest, you typically need:
What is the PE and PB ratio of ACRIVON THERAPEUTICS, INC.?
The PE ratio of ACRIVON THERAPEUTICS, INC. is N/A and the PB ratio is 0.68.